FDX2 and ISCU Gene Variations Lead to Rhabdomyolysis with Distinct Severity and Iron Regulation - Plateforme d’immortalisation MyoLine – CRM
Article Dans Une Revue Neurology Genetics Année : 2022

FDX2 and ISCU Gene Variations Lead to Rhabdomyolysis with Distinct Severity and Iron Regulation

Emmanuelle Lacène
  • Fonction : Auteur

Résumé

Background and ObjectivesTo determine common clinical and biological traits in 2 individuals with variants in ISCU and FDX2, displaying severe and recurrent rhabdomyolyses and lactic acidosis.MethodsWe performed a clinical characterization of 2 distinct individuals with biallelic ISCU or FDX2 variants from 2 separate families and a biological characterization with muscle and cells from those patients.ResultsThe individual with FDX2 variants was clinically more affected than the individual with ISCU variants. Affected FDX2 individual fibroblasts and myoblasts showed reduced oxygen consumption rates and mitochondrial complex I and PDHc activities, associated with high levels of blood FGF21. ISCU individual fibroblasts showed no oxidative phosphorylation deficiency and moderate increase of blood FGF21 levels relative to controls. The severity of the FDX2 individual was not due to dysfunctional autophagy. Iron was excessively accumulated in ISCU-deficient skeletal muscle, which was accompanied by a downregulation of IRP1 and mitoferrin2 genes and an upregulation of frataxin (FXN) gene expression. This excessive iron accumulation was absent from FDX2 affected muscle and could not be correlated with variable gene expression in muscle cells.DiscussionWe conclude that FDX2 and ISCU variants result in a similar muscle phenotype, that differ in severity and skeletal muscle iron accumulation. ISCU and FDX2 are not involved in mitochondrial iron influx contrary to frataxin.
Fichier principal
Vignette du fichier
NG2021016985.pdf (654.78 Ko) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03604086 , version 1 (01-06-2022)

Licence

Identifiants

Citer

Sebastián Montealegre, Élise Lebigot, Hugo Debruge, Norma Beatriz Romero, Bénédicte Héron, et al.. FDX2 and ISCU Gene Variations Lead to Rhabdomyolysis with Distinct Severity and Iron Regulation. Neurology Genetics, 2022, 8 (1), ⟨10.1212/NXG.0000000000000648⟩. ⟨hal-03604086⟩
230 Consultations
56 Téléchargements

Altmetric

Partager

More